OncoLens is a technology company that focuses on enhancing cancer treatment planning and management through a HIPAA-compliant mobile and web-based platform. Its innovative solution consolidates various data sets, oncology care teams, and stakeholders into a single platform, facilitating multi-disciplinary treatment planning and improving clinical decision-making. By automating tumor board management and survivorship care planning, OncoLens streamlines business processes and enhances accreditation and quality reporting. The platform's AI-driven clinical decision support capabilities empower physicians to collaboratively create and discuss individualized treatment plans for cancer patients, ultimately aiming to improve patient outcomes and streamline oncology workflows.
Shimmer
Seed Round in 2024
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability.
Feel Therapeutics
Venture Round in 2024
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
Canid is a company focused on enhancing the vaccination process for pediatricians by streamlining vaccination record management. Its innovative scanning system reduces the need for manual data entry, facilitating the automatic upload of vaccination information into state registries. The company's dashboard and process tools provide administrative consulting, ensure vaccine margins, automate workflow, and manage vaccine inventory. This comprehensive approach allows state officials and pediatric practitioners to concentrate on their core responsibilities, ultimately improving efficiency in vaccination administration.
AngelEye Health
Series B in 2022
AngelEye Health is a developer of a tele-engagement platform designed to integrate parents into the care team during their child's stay in neonatal intensive care units (NICUs) and pediatric units. The company offers a comprehensive, HIPAA-compliant solution that includes bedside cameras, patient communication tools, feeding management systems, and targeted educational resources. These services enhance care team workflows and provide families with improved access to their child's treatment plans and progress through any connected device. By fostering meaningful care experiences, AngelEye Health aims to improve family satisfaction, enhance care delivery efficiency, and ultimately elevate the quality of care for patients.
Biotia, Inc. is a health tech company based in New York, founded in 2016. It specializes in developing software and laboratory technology that leverage next-generation DNA sequencing and artificial intelligence to enhance infectious disease discovery. Biotia's solutions focus on microbial surveillance and tailored sequencing to reduce hospital-acquired infections. By enabling clinicians and researchers to identify and stop pathogens before patients fall ill, Biotia aims to improve patient treatment and health outcomes, thereby contributing to safer healthcare environments.
STRIVE operates a fitness platform designed to enhance muscle performance for athletes, military personnel, and industrial workers. The company employs advanced sensors integrated into compression clothing to collect detailed muscle and movement data through methods such as surface electromyography and accelerometers. This information enables users to monitor muscle activity, track fatigue, and prevent injuries, ultimately promoting improved performance. STRIVE's technology is utilized by elite athletes across various sports, including NCAA, NFL, and MLS, providing them with actionable insights to maintain peak performance.
Mployer Advisor
Seed Round in 2022
Mployer Advisor is an independent platform designed to assist employers in researching, reviewing, and evaluating insurance brokers. It operates as a comprehensive directory that enables employers to find the most suitable insurance broker based on their specific needs. The platform offers actionable data, allowing users to search for and assess insurance brokers in their area, along with the various options available for selecting insurance advisors. By promoting transparency within the insurance brokerage industry, Mployer Advisor empowers employers to make informed decisions regarding their insurance needs.
curie ai
Seed Round in 2022
Curie AI is a tech-enabled respiratory care company providing virtual personalized disease management through proprietary AI that passively detects symptoms. This approach results in high adherence, reduction in adverse events, cost savings, and improving overall quality of life for people with chronic respiratory conditions
Heading Health
Seed Round in 2022
Heading Health is a technology-enabled mental health platform dedicated to enhancing access to affordable care. The company provides personalized treatment solutions that utilize evidence-based therapeutics and advanced technologies such as transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine. By leveraging these tools, Heading Health aims to deliver effective and convenient mental health services, helping patients achieve meaningful outcomes and improved well-being.
Zeit Medical
Seed Round in 2021
Zeit Medical specializes in the development of innovative technology for diagnosing and treating neurological injuries. Founded in 2019 by Urs Naber and Orestis Vardoulis, the company has created a headband that continuously monitors the electrical activity of the brain. This device integrates seamlessly with existing electroencephalogram (EEG) systems and facilitates automated pre-screening and annotation of extensive datasets. By identifying specific patterns in EEG readings, Zeit Medical enables physicians to detect the onset of strokes and provide precise treatment, significantly improving patient outcomes in neurological care.
GritWell
Seed Round in 2021
GritWell Ltd is a digital health platform established in 2018, based in San Francisco, California. The company focuses on addressing chronic health conditions by shifting the emphasis from symptom management to identifying and treating root causes. GritWell connects patients suffering from various chronic symptoms, such as insomnia, migraines, digestive issues, anxiety, and joint pain, with nutritionists, health coaches, and holistic practitioners. Its platform offers personalized care through clinically validated symptom assessments and facilitates secure video consultations, direct messaging, and an online portal for scheduling and managing patient records. By integrating natural treatments and providing tailored treatment plans, GritWell aims to enhance patient outcomes and support a holistic approach to health.
Moonlight Therapeutics
Series A in 2021
Moonlight Therapeutics, Inc. is a biotechnology company based in Atlanta, Georgia, that specializes in developing targeted immunotherapy treatments for food allergies. Founded in 2017, the company employs its proprietary Targeted Allergen Specific Immunotherapy (TASIS) platform to deliver allergens to immune cells in the skin. This innovative approach allows for the treatment of individual or multiple food allergies in a safe and effective manner. Among its offerings, Moonlight Therapeutics has developed a novel intradermal therapy that provides desensitization for peanut allergies through a user-friendly stamp that is worn for just a few minutes. The company's mission is to improve the quality of life for individuals suffering from food allergies by providing effective and patient-friendly therapeutic options.
Feel Therapeutics
Seed Round in 2021
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
OncoLens is a technology company that focuses on enhancing cancer treatment planning and management through a HIPAA-compliant mobile and web-based platform. Its innovative solution consolidates various data sets, oncology care teams, and stakeholders into a single platform, facilitating multi-disciplinary treatment planning and improving clinical decision-making. By automating tumor board management and survivorship care planning, OncoLens streamlines business processes and enhances accreditation and quality reporting. The platform's AI-driven clinical decision support capabilities empower physicians to collaboratively create and discuss individualized treatment plans for cancer patients, ultimately aiming to improve patient outcomes and streamline oncology workflows.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.